Skip to content

Drug interactions

Glibenclamide + Sparsentan

Severity: Moderate

Glibenclamide and Sparsentan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sparsentan induces CYP2C9, which may lower glyburide exposure and weaken glycemic control. The effect would develop over days after sparsentan is started.

What this interaction means in plain words

Glibenclamide and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Glibenclamide belongs to Endocrine; Sparsentan belongs to Genitourinary.

Evidence level: Moderate

Why it happens

CYP2C9 induction by sparsentan increases glyburide metabolism.

What to do

Monitor blood glucose and HbA1c after starting sparsentan and increase the glyburide dose if needed. Reassess the dose when sparsentan is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glibenclamide and Sparsentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glibenclamide with Sparsentan?

MediHelp rates the interaction as moderate. Glibenclamide and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sparsentan induces CYP2C9, which may lower glyburide exposure and weaken glycemic control. The effect would develop over days after sparsentan is started.

How serious is the interaction between Glibenclamide and Sparsentan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c after starting sparsentan and increase the glyburide dose if needed. Reassess the dose when sparsentan is stopped.

What other medicines interact with Glibenclamide?

MediHelp also lists interactions of Glibenclamide with, for example, Bosentan, Cholic acid, Ciprofloxacin. The full list is on the Glibenclamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in